Laboratory & Diagnostic Services
Access to quality TB diagnostics including molecular tests (CBNAAT/TrueNat), culture & DST, and X-ray screening across India.
India's National Tuberculosis Elimination Programme is committed to ending TB by 2025—5 years ahead of the global Sustainable Development Goal. Join 140 crore Indians in this mission.
Comprehensive programmes covering all aspects of TB elimination in India
Access to quality TB diagnostics including molecular tests (CBNAAT/TrueNat), culture & DST, and X-ray screening across India.
Programmatic management of Drug-Resistant TB including shorter MDR-TB regimens and newer drugs like Bedaquiline.
Direct Benefit Transfer of ₹500/month for nutritional support to TB patients throughout their treatment journey.
Dedicated guidelines, child-friendly drug formulations, and support for diagnosing and treating TB in children under 15 years.
Engaging private healthcare providers through schemes like PPSA to ensure comprehensive TB care across all sectors.
PMTPT — Provision of 6-month or 3HP regimen to close contacts and high-risk groups to prevent progression to active TB.
Key programme indicators reflecting India's commitment to ending TB
Access guidelines, reports, IEC materials, and operational documents
Learn from states that have made outstanding progress in TB elimination
Follow #TBMuktBharat for the latest campaign updates and awareness content
National workshop on differentiated TB care concludes in New Delhi.